Professor Comanor and Professor Schweitzer have selected the most significant articles by leading academics, in order to offer a blend of standard economic interpretations of pharmaceutical policy and important new topics including biosimilars, insurance coverage for pharmaceuticals, price-fixing and direct-to-consumer advertising.
An authoritative new introduction by the editors provides an insightful guide to these important topics.
34 articles, dating from 1987 to 2011
Contributors include: E.R. Berndt, R.E. Caves, P.M. Danzon, R.G. Frank, H. Grabowski, R. Henderson, F.R. Lichtenberg, F.M. Scherer, F.M. Scott Morton, M.D. Whinston